{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:58:52Z","timestamp":1753891132445,"version":"3.41.2"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002910","name":"F\u00e9d\u00e9ration Wallonie-Bruxelles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002910","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008367","name":"Universit\u00e9 Libre de Bruxelles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008367","name":"Universit\u00e9 Libre de Bruxelles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008367","name":"Universit\u00e9 Libre de Bruxelles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008367","name":"Universit\u00e9 Libre de Bruxelles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>This work identifies the protein \u201cmacrophage infectivity potentiator\u201d of <jats:italic>Trypanosoma cruzi<\/jats:italic> trypomastigotes, as supporting a new property, namely a pro-type 1 immunostimulatory activity on neonatal cells. In its recombinant form (rTcMIP), this protein triggers the secretion of the chemokines CCL2 and CCL3 by human umbilical cord blood cells from healthy newborns, after 24h <jats:italic>in vitro<\/jats:italic> culture. Further stimulation for 72h results in secretion of IFN-\u03b3, provided cultures are supplemented with IL-2 and IL-18. rTcMIP activity is totally abolished by protease treatment and is not associated with its peptidyl-prolyl cis-trans isomerase enzymatic activity. The ability of rTcMIP to act as adjuvant was studied <jats:italic>in vivo<\/jats:italic> in neonatal mouse immunization models, using acellular diphtheria-tetanus-pertussis-vaccine (DTPa) or ovalbumin, and compared to the classical alum adjuvant. As compared to the latter, rTcMIP increases the IgG antibody response towards several antigens meanwhile skewing antibody production towards the Th-1 dependent IgG2a isotype. The amplitude of the rTcMIP adjuvant effect varied depending on the antigen and the co-presence of alum. rTcMIP did by contrast not increase the IgE response to OVA combined with alum. The discovery of the rTcMIP immunostimulatory effect on neonatal cells opens new possibilities for potential use as pro-type 1 adjuvant for neonatal vaccines. This, in turn, may facilitate the development of more efficient vaccines that can be given at birth, reducing infection associated morbidity and mortality which are the highest in the first weeks after birth.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1138526","type":"journal-article","created":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T10:55:21Z","timestamp":1679568921000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Macrophage-infectivity potentiator of Trypanosoma cruzi (TcMIP) is a new pro-type 1 immuno-stimulating protein for neonatal human cells and vaccines in mice"],"prefix":"10.3389","volume":"14","author":[{"given":"Magdalena","family":"Radwanska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"de Lemos Esteves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loes","family":"Linsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Coltel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Cencig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joelle","family":"Widart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-C\u00e9cile","family":"Massart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9verine","family":"Colson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Di Paolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Percier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarra","family":"Ait Djebbara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Guillonneau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Flamand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin","family":"De Pauw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Marie","family":"Fr\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Carlier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carine","family":"Truyens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-021-00163-y","article-title":"Emerging concepts in the science of vaccine adjuvants","volume":"20","author":"Pulendran B","year":"2021","journal-title":"Nat Rev Drug Discovery"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibtech.2018.10.004","article-title":"Applications of immunomodulatory immune synergies to adjuvant discovery and vaccine development","volume":"37","author":"Tom","year":"2019","journal-title":"Trends Biotechnol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.662218","article-title":"Precision vaccine development: Cues from natural immunity","volume":"12","author":"Barman","year":"2021","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/j.0818-9641.2004.01272.x","article-title":"Vaccine adjuvants: Current state and future trends","volume":"82","author":"Petrovsky","year":"2004","journal-title":"Immunol Cell Biol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.9.5430-5434.2000","article-title":"Maternal trypanosoma cruzi infection upregulates capacity of uninfected neonate cells to produce pro- and anti-inflammatory cytokines","volume":"68","author":"Vekemans","year":"2000","journal-title":"Infect Immun"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000571","article-title":"Maternal infection with trypanosoma cruzi and congenital chagas disease induce a trend to a type 1 polarization of infant immune responses to vaccines","volume":"3","author":"Dauby","year":"2009","journal-title":"PloS Negl Trop Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-017-0653-x","article-title":"Transfer of maternal immunity and programming of the newborn immune system","volume":"39","author":"Jennewein","year":"2017","journal-title":"Semin Immunopathol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.01854","article-title":"Congenital transmission of trypanosoma cruzi: A review about the interactions between the parasite, the placenta, the maternal and the Fetal\/Neonatal immune responses","volume":"10","author":"Kemmerling","year":"2019","journal-title":"Front Microbiol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2015.07.016","article-title":"Congenital chagas disease as an ecological model of interactions between trypanosoma cruzi parasites, pregnant women, placenta and fetuses","volume":"151","author":"Carlier","year":"2015","journal-title":"Acta Trop"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1590\/S0074-02762009000700021","article-title":"A new consensus for trypanosoma cruzi intraspecific nomenclature: Second revision meeting recommends TcI to TcVI","volume":"104","author":"Zingales","year":"2009","journal-title":"MemInstOswaldo Cruz"},{"key":"B11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1365-3024.1994.tb00325.x","article-title":"Trypanosoma cruzi infection in mice induces a polyisotypic hypergammaglobulinaemia and parasite-specific response involving high IgG2a concentrations and highly avid IgG1 antibodies","volume":"16","author":"el Bouhdidi","year":"1994","journal-title":"Parasite Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001584","article-title":"Multiple mitochondrial introgression events and heteroplasmy in trypanosoma cruzi revealed by maxicircle MLST and next generation sequencing","volume":"6","author":"Messenger","year":"2012","journal-title":"PloS Negl Trop Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1995.tb07245.x","article-title":"Secretion by trypanosoma cruzi of a peptidyl-prolyl cis-trans isomerase involved in cell infection","volume":"14","author":"Moro","year":"1995","journal-title":"EMBO J"},{"unstructured":"Guidance for industry: Pyrogen and endotoxins testing: Questions and answersUS Food drug adm2019","key":"B14"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/jps.22267","article-title":"Acceptable levels of endotoxin in vaccine formulations during preclinical research","volume":"100","author":"Brito","year":"2011","journal-title":"J Pharm Sci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2008.12.003","article-title":"Evaluating the effects of immunosuppressants on human immunity using cytokine profiles of whole blood","volume":"45","author":"Liu","year":"2009","journal-title":"Cytokine"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.00015-14","article-title":"Microbial peptidyl-prolyl cis\/trans isomerases (PPIases): Virulence factors and potential alternative drug targets","volume":"78","author":"\u00dcnal","year":"2014","journal-title":"Microbiol Mol Biol Rev MMBR"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1126\/science.3107127","article-title":"Interferon-gamma and b cell stimulatory factor-1 reciprocally regulate ig isotype production","volume":"236","author":"Snapper","year":"1987","journal-title":"Science"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.5RU0319-105R","article-title":"Dissecting the defects in the neonatal CD8+ T-cell response","volume":"106","author":"Fike","year":"2019","journal-title":"J Leukoc Biol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/nri2075","article-title":"Innate immunity of the newborn: Basic mechanisms and clinical correlates","volume":"7","author":"Levy","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/nature12675","article-title":"Immunosuppressive CD71+ erythroid cells compromise neonatal host defence against infection","volume":"504","author":"Elahi","year":"2013","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s12104-018-9844-1","article-title":"Backbone chemical shift assignment of macrophage infectivity potentiator virulence factor of trypanosoma cruzi","volume":"13","author":"Lopez","year":"2019","journal-title":"Biomol NMR Assign"},{"key":"B23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1093\/embo-reports\/kvf009","article-title":"Trypanosoma cruzi macrophage infectivity potentiator has a rotamase core and a highly exposed alpha-helix","volume":"3","author":"Pereira","year":"2002","journal-title":"EMBO Rep"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2015.1095638","article-title":"Vaccine potential of bacterial macrophage infectivity potentiator (MIP)-like peptidyl prolyl cis\/trans isomerase (PPIase) proteins","volume":"14","author":"Humbert","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"B25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1515\/bmc-2018-0007","article-title":"Interferon-gamma (IFN-\u03b3): Exploring its implications in infectious diseases","volume":"9","author":"Kak","year":"2018","journal-title":"Biomol Concepts"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2010.00961.x","article-title":"Regulation of the ifng locus in the context of T-lineage specification and plasticity","volume":"238","author":"Balasubramani","year":"2010","journal-title":"Immunol Rev"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2015.18","article-title":"Harnessing the plasticity of CD4(+) T cells to treat immune-mediated disease","volume":"16","author":"DuPage","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2017.1384313","article-title":"Chemokines as adjuvants for immunotherapy: Implications for immune activation with CCL3","volume":"13","author":"Schaller","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/82_2010_20","article-title":"Role of chemokines in the biology of natural killer cells","volume":"341","author":"Maghazachi","year":"2010","journal-title":"Curr Top Microbiol Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1146\/annurev-immunol-032713-120145","article-title":"Chemokines and chemokine receptors: Positioning cells for host defense and immunity","volume":"32","author":"Griffith","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00084-18","article-title":"Factors that influence the immune response to vaccination","volume":"32","author":"Zimmermann","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"B32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.coi.2017.07.010","article-title":"Towards an evidence based approach for the development of adjuvanted vaccines","volume":"47","author":"O\u2019Hagan","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"w13940","DOI":"10.4414\/smw.2014.13940","article-title":"Vaccine adjuvants\u2013understanding molecular mechanisms to improve vaccines","volume":"144","author":"Egli","year":"2014","journal-title":"Swiss Med Wkly"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2017.03.009","article-title":"Protecting the newborn and young infant from infectious diseases: Lessons from immune ontogeny","volume":"46","author":"Kollmann","year":"2017","journal-title":"Immunity"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/v14030520","article-title":"Strategies to develop a mucosa-targeting vaccine against emerging infectious diseases","volume":"14","author":"Feng","year":"2022","journal-title":"Viruses"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.91020","article-title":"TLR7\/8 adjuvant overcomes newborn hyporesponsiveness to pneumococcal conjugate vaccine at birth","volume":"2","author":"Dowling","year":"2017","journal-title":"JCI Insight"},{"key":"B37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41421-021-00370-2","article-title":"CoVac501, a self-adjuvanting peptide vaccine conjugated with TLR7 agonists, against SARS-CoV-2 induces protective immunity","volume":"8","author":"Long","year":"2022","journal-title":"Cell Discovery"},{"key":"B38","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/B978-0-12-396548-6.00007-X","article-title":"TLR ligand-peptide conjugate vaccines: Toward clinical application","volume":"114","author":"Zom","year":"2012","journal-title":"Adv Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.it.2014.04.007","article-title":"Ontogeny of early life immunity","volume":"35","author":"Dowling","year":"2014","journal-title":"Trends Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2019.09.002","article-title":"MOMP and MIP DNA-loaded bacterial ghosts reduce the severity of lung lesions in mice after chlamydia psittaci respiratory tract infection","volume":"224","author":"Zhou","year":"2019","journal-title":"Immunobiology"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.2.1158","article-title":"The proinflammatory cytokine response to chlamydia trachomatis elementary bodies in human macrophages is partly mediated by a lipoprotein, the macrophage infectivity potentiator, through TLR2\/TLR1\/TLR6 and CD14","volume":"180","author":"Bas","year":"2008","journal-title":"J Immunol Baltim Md 1950"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.05.069","article-title":"Immunization with recombinant truncated neisseria meningitidis-macrophage infectivity potentiator (rT-Nm-MIP) protein induces murine antibodies that are cross-reactive and bactericidal for neisseria gonorrhoeae","volume":"36","author":"Humbert","year":"2018","journal-title":"Vaccine"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00939-17","article-title":"Peptidyl-Prolyl-cis\/trans-Isomerases mip and PpiB of legionella pneumophila contribute to surface translocation, growth at suboptimal temperature, and infection","volume":"87","author":"Rasch","year":"2019","journal-title":"Infect Immun"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.861489","article-title":"Update on the neisseria macrophage infectivity potentiator-like PPIase protein","volume":"12","author":"Christodoulides","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/prot.21908","article-title":"Structure-based classification of 45 FK506-binding proteins","volume":"72","author":"Somarelli","year":"2008","journal-title":"Proteins"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01815-14","article-title":"Recombinant protein truncation strategy for inducing bactericidal antibodies to the macrophage infectivity potentiator protein of neisseria meningitidis and circumventing potential cross-reactivity with human FK506-binding proteins","volume":"83","author":"Bielecka","year":"2015","journal-title":"Infect Immun"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaz9447","article-title":"Vaccination strategies to enhance immunity in neonates","volume":"368","author":"Kollmann","year":"2020","journal-title":"Science"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12889","article-title":"Modulation of immune responses using adjuvants to facilitate therapeutic vaccination","volume":"296","author":"Schijns","year":"2020","journal-title":"Immunol Rev"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1138526\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T10:55:30Z","timestamp":1679568930000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1138526\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,23]]},"references-count":48,"alternative-id":["10.3389\/fimmu.2023.1138526"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1138526","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2023,3,23]]},"article-number":"1138526"}}